Financials

  • Market Capitalization 367.58 M
  • Employee 78
  • Founded 2018
  • CEO N/A
  • Website www.centurytx.com
  • Headquarter Delaware, United States
  • FIGI BBG00PM8N5W0
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.11
Relación precio/flujo de caja
0.79

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3094
CTNM
Contineum Therapeutics, Inc. - Common stock
17.00 USD-1.45%-1.11%+19.97%+11.33%392.69 M USD
3108
EYPT
EyePoint, Inc. - Common Stock
4.47 USD-3.46%-15.98%-62.69%-62.75%385.37 M USD
3172
FHTX
Foghorn Therapeutics Inc. - Common Stock
6.00 USD-3.54%-15.13%+16.73%+47.06%356.31 M USD
3173
LYEL
Lyell Immunopharma, Inc. - Common Stock
14.52 USD-0.62%-6.50%+12.56%-39.98%355.81 M USD

Noticias